Trial Profile
Integrilin plus stenting to avoid myocardial necrosis trial. Pilot Study.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Jul 2011
Price :
$35
*
At a glance
- Drugs Eptifibatide (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms ISTANT
- 22 Jul 2011 New trial record